Medicare Enrolled
Dr. Aliya Khan, MD
Clinical & Laboratory Immunology (Internal Medicine) Physician · Dayton, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Aliya Khan is a clinical & laboratory immunology physician in Dayton, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 120,512 Medicare services across 912 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $1,638 from 32 pharmaceutical and/or device companies across 87 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical & laboratory immunology (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 50% volume in OH
$1,638 industry payments
Medicare Practice Summary
Medicare Utilization ↗120,512
Medicare services
Top 50% in OH for clinical & laboratory immunology (internal medicine) physician
912
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,026 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 83,960 | $5 | $8 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 14,784 | $38 | $96 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
7,875 | $34 | $75 |
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
4,240 | $30 | $116 |
| Denosumab injection (Prolia/Xgeva) | 3,900 | $18 | $32 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,440 | $26 | $139 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
536 | $16 | $108 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
517 | $48 | $828 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
465 | $88 | $171 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
192 | $97 | $830 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
87 | $21 | $107 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
85 | $14 | $126 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
82 | $11 | $54 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $63 | $101 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
76 | $36 | $243 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
37 | $4 | $11 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
32 | $23 | $83 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
27 | $9 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $120 | $257 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
22 | $23 | $92 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $29 | $36 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
18 | $76 | $96 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
14 | $30 | $123 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.4% high complexity
89.0% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,638
Total received (2018-2024)
Avg $234/year across 7 years
Top 50% in OH for clinical & laboratory immunology (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
87
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,571 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$310
2023
$152
2022
$61
2021
$66
2020
$278
2019
$390
2018
$381
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$66
Amgen Inc.
$50
Novartis Pharmaceuticals Corporation
$38
Organon Llc
$31
Janssen Biotech, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Aurinia Pharma U.S., Inc.
$25
DePuy Synthes Sales Inc.
$24
Mallinckrodt Hospital Products Inc.
$20
Top 3 companies account for 49.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$153
Amgen Inc.
$139
Novartis Pharmaceuticals Corporation
$120
Janssen Biotech, Inc.
$115
PFIZER INC.
$95
UCB, Inc.
$94
AbbVie, Inc.
$93
Aurinia Pharma U.S., Inc.
$87
Actelion Pharmaceuticals US, Inc.
$69
Horizon Therapeutics plc
$65
AbbVie Inc.
$54
Genentech USA, Inc.
$54
Regeneron Healthcare Solutions, Inc.
$44
E.R. Squibb & Sons, L.L.C.
$42
SANOFI-AVENTIS U.S. LLC
$40
GlaxoSmithKline, LLC.
$38
Organon Llc
$31
AstraZeneca Pharmaceuticals LP
$31
Horizon Pharma plc
$27
AIMMUNE THERAPEUTICS, INC.
$27
Radius Health, Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
DePuy Synthes Sales Inc.
$24
Sobi, Inc
$22
Mallinckrodt Hospital Products Inc.
$20
Fresenius Kabi USA, LLC
$19
CSL Behring
$17
Orthogenrx Inc.
$16
Bioventus LLC
$15
Merck Sharp & Dohme Corporation
$12
Takeda Pharmaceuticals U.S.A., Inc.
$12
FIDIA PHARMA USA INC.
$9
Top 3 companies account for 25.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · COSENTYX · Cimzia · Durolane · EVENITY · Enbrel · FASENRA · GenVisc 850 · HADLIMA · HUMIRA · HYALGAN · Hizentra · Humira · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · LUPKYNIS · NUCALA · OFEV · ORENCIA · ORTHOVISC · PALFORZIA · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Repatha · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · SYNVISC-ONE · TREMFYA · Tavneos · Tymlos · UPTRAVI · Uloric · XELJANZ · XOLAIR
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Clinical & laboratory immunology physicians within 10 mi
1
Per 100K population
0.2
County median income
$64,403
Nearest hospital
MIAMI VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Khan performed 83,960 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $1,638 from 32 companies across 87 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other clinical & laboratory immunology physicians in Dayton?
Dr. Khan's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Clinical & Laboratory Immunology Physicians in Dayton
Browse clinical & laboratory immunology physicians in Dayton ranked by procedure volume and transparency data.
Highest volume
Top Clinical & Laboratory Immunology Physicians in OH
Clinical & laboratory immunology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical & Laboratory Immunology Physicians in OH
Which OH clinical & laboratory immunology physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology